Brolucizumab Shows Promising Outcomes for Diabetic Macular Edema Care Jacinthlyn Sylvia3 Dec 2023 6:00 PM ISTAn update of a 52-week clinical trial unveiled promising results of brolucizumab compared to the standard aflibercept in enhancing diabetic macular...
Brolucizumab as good as aflibercept for improving clinical outcomes in Diabetic Macular Edema Outcomes: JAMA Jacinthlyn Sylvia19 Nov 2023 5:00 PM ISTA recent 52-week phase 3 clinical trial published in the Journal of American Medical Association compared the efficacy and safety of brolucizumab...
Bayer Aflibercept 8 mg recommended for approval in EU Ruchika Sharma15 Nov 2023 1:00 PM ISTBerlin: Bayer has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a...
Lupin collaborate with Amman Pharma for marketing, commercialization of Ranibizumab in Middle East region Ruchika Sharma11 Nov 2023 10:00 AM ISTMumbai: Global Pharma major Lupin Limited has partnered with Amman Pharmaceuticals Industries, a pharmaceutical manufacturer with operations across...
Roche gets CDSCO panel Nod To study safety, and efficacy of Faricimab Intravitreal injection Dr. Divya Colin29 Oct 2023 6:00 PM ISTNew Delhi: The drug major Roche has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Long-term Anti-VEGF Therapy for Diabetic Macular Edema Linked to Declining Renal Function Dr. Kamal Kant Kohli27 Sept 2023 8:00 PM ISTLong-term treatment with intravitreal anti-vascular endothelial growth factor (VEGF) therapy may be associated with a continuous decline in estimated...
Levosulpiride Shows Potential of Treating Diabetic Eye Conditions Jacinthlyn Sylvia24 Sept 2023 8:00 PM ISTA recent study published in the Eye Journal that the prokinetic drug levosulpiride may hold significant promise in the treatment of diabetic eye...
Fluocinolone acetonide intravitreal implant stabilises IOP among Diabetic Macular Edema patients Dr. Kamal Kant Kohli17 Sept 2023 8:00 PM ISTA recent analysis of the phase 4 PALADIN study suggests that the 0.19-mg fluocinolone acetonide (FAc) intravitreal implant, known as ILUVIEN, has a...
Regeneron Pharma Eylea HD injection approved by USFDA for treatment of Wet age-related macular degeneration, diabetic macular edema, diabetic retinopathy Ruchika Sharma21 Aug 2023 1:30 PM ISTTarrytown: Regeneron Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved EYLEA HD...
Roche Canada, pan-Canadian Pharmaceutical Alliance complete negotiations for VABYSMO to treat Neovascular neovascular AMD, DME Ruchika Sharma30 May 2023 5:46 PM ISTVABYSMO is a humanized bispecific immunoglobulin G1(IgG1) antibody that acts through inhibition of both Ang-2 and vascular endothelial growth factor A...
Bevacizumab substantially cost effective compared with aflibercept monotherapy for diabetic macular edema: JAMA Dr Ishan Kataria10 March 2023 8:00 PM ISTIntravitreous anti-vascular endothelial growth factor (VEGF) injections are the standard treatment for eyes with vision loss from diabetic macular...
Roche gets CDSCO Panel nod to import, market ophthalmic drug Faricimab solution Dr. Divya Colin6 March 2023 6:00 PM ISTNew Delhi: Granting the request for waiver of Phase III clinical trial of Faricimab 6mg/0.05mL solution for Intravitreal Injection in the country, the...
